A comprehensive review of the provided sources—spanning peer-reviewed articles, patents, and commercial antibody documentation—reveals no direct mention of "SPCC757.11c Antibody." This includes:
Search Results1–8: These focus on antibodies targeting CD117, CD11c, mutant p53, or CD7, but none describe an antibody designated as "SPCC757.11c."
Typographical Error: The designation "SPCC757.11c" may contain a typographical error. For example:
CD11c Antibodies: Multiple CD11c-targeting antibodies are documented (e.g., Clone ICRF 3.9 , Clone EP1347Y , Clone HL3 ). These target integrin αX (CD11c), a marker for dendritic cells and myeloid subsets.
Clone Numbering: The "757.11c" suffix might refer to a clone ID, but no matches exist in the reviewed literature.
If "SPCC757.11c" refers to a novel, unpublished antibody, its characteristics would require validation through primary research. Key attributes of analogous antibodies include:
Primary Literature Search: Use databases like PubMed or Google Scholar with precise search terms (e.g., "SPCC757.11c Antibody," "Clone 757.11c").
Commercial Catalogs: Check antibody vendors (e.g., R&D Systems, Abcam) for unreleased products.
Patent Databases: Explore USPTO or WIPO for pending patents related to this designation.
The absence of "SPCC757.11c" in the provided sources underscores the need for caution. Claims about its specificity, structure, or applications cannot be substantiated without direct evidence.
KEGG: spo:SPCC757.11c
STRING: 4896.SPCC757.11c.1
SPCC757.11c is a protein in Schizosaccharomyces pombe (fission yeast). While specific information about this particular protein is limited in the search results, the nomenclature follows the standard S. pombe genome annotation system where SPCC indicates chromosome location, and the subsequent numbers represent specific coordinates. Antibodies against such proteins are valuable for studying protein expression, localization, interactions, and function in fundamental cellular processes. Similar approaches have been successfully used with other yeast proteins such as those studied in transcription regulation research, as seen with the Atf1 and Pcr1 transcription factors .
Antibody validation should follow a multi-step approach similar to that used for other research antibodies. From the methodology described for monoclonal antibodies in search result , researchers should:
Perform immunolabeling reactions with both positive and negative controls
Conduct FACS analyses to confirm binding specificity
Evaluate cross-reactivity with related proteins
Verify specificity through knockdown or knockout of the target protein
Compare results with alternative detection methods (Western blot, immunoprecipitation)
As described in the validation process for other antibodies, "cells were labeled for 30 minutes with hybridoma supernatants or purified mAbs... both singly and in combination with other cell-surface markers... Cells were next washed in FACS buffer and incubated for 30 minutes with conjugated fluorophore isotype matched secondary antibodies" .
Based on standard antibody research protocols and the methodologies mentioned in search results, researchers should include:
Isotype controls (matched to the antibody class and species)
Secondary antibody-only controls
Known positive and negative cell/tissue samples
Competitive inhibition controls where applicable
Genetic controls (e.g., SPCC757.11c knockout or knockdown strains)
For immunofluorescence experiments, similar to those conducted with stem cell antibodies, "For OCT4 multicolor analyses, cells were sequentially live cell immunostained for cell-surface markers followed by fixation, permeabilization and intracellular immunostaining" . This approach would be applicable when combining SPCC757.11c detection with other markers.
Epitope selection is critical for antibody functionality across different applications. While direct information about SPCC757.11c epitopes is not available in the search results, lessons from other antibody development efforts suggest:
Linear epitopes are generally more suitable for denatured applications (Western blot)
Conformational epitopes may better preserve native protein recognition (immunoprecipitation, flow cytometry)
Surface-exposed regions should be targeted for live-cell applications
The extensive validation process described for other antibodies demonstrates that verification across multiple applications is essential: "Extracellular, intracellular, single, and multicolour immunolabeling reactions and FACS analyses were all performed" . This multi-platform validation approach should be applied to SPCC757.11c antibodies as well.
When encountering inconsistent results with SPCC757.11c antibodies across platforms like Western blot, immunoprecipitation, and immunofluorescence, researchers should:
Assess buffer compatibility (detergents, salts, pH conditions may affect epitope accessibility)
Evaluate fixation effects (paraformaldehyde versus methanol fixation can yield different results)
Compare fresh versus frozen samples (protein degradation may affect results)
Examine epitope masking through protein interactions or post-translational modifications
Consider protein expression levels and detection sensitivity thresholds
For example, the differential detection of PM/Scl-75 and PM/Scl-100 antibodies highlighted in search result demonstrates how antigen expression systems can impact detection: "When the PM/Scl-100 antigen expressed by baculovirus was used, only 11 patients (3.9%) showed reactivity" compared to higher detection rates with E. coli-expressed antigen .
Optimization of antibody concentration requires systematic titration across different applications:
Start with manufacturer recommendations if available
Perform dilution series experiments (typically 1:100 to 1:10,000 for primary antibodies)
Evaluate signal-to-noise ratio at each concentration
Consider blocking reagent optimization in parallel
Test multiple incubation times and temperatures
For flow cytometry applications, following protocols similar to those described in search result : "cells were labeled for 30 minutes with hybridoma supernatants or purified mAbs... followed by washing in FACS buffer and incubation for 30 minutes with conjugated fluorophore isotype matched secondary antibodies" .
Based on general antibody principles and information from the search results about other antibodies:
| Feature | Polyclonal SPCC757.11c Antibodies | Monoclonal SPCC757.11c Antibodies |
|---|---|---|
| Epitope recognition | Multiple epitopes | Single epitope |
| Batch-to-batch variability | Higher | Lower |
| Signal amplification | Often stronger due to multiple binding sites | May require signal enhancement |
| Cross-reactivity | Potentially higher | Generally more specific |
| Cost and production | Usually less expensive to produce | Higher development costs |
| Best applications | Western blot, immunoprecipitation | Flow cytometry, highly specific assays |
As noted in search result , monoclonal antibodies offer particular advantages for specific applications: "These antibodies are significant because they enable new explorations... The antibodies should be useful for gaining a better understanding... enriching for... cells, removing... cells, and also for performing similar functions with subsets" .
While specific protocols for SPCC757.11c are not detailed in the search results, methodological approaches for similar applications suggest:
For membrane or surface proteins: 2-4% paraformaldehyde (10-15 minutes) with gentle permeabilization (0.1% Triton X-100 or 0.1% saponin)
For intracellular proteins: Consider methanol fixation (100%, -20°C, 10 minutes) which simultaneously fixes and permeabilizes
For dual detection of surface and intracellular markers: "cells were sequentially live cell immunostained for cell-surface markers followed by fixation, permeabilization and intracellular immunostaining"
Optimization may be necessary depending on the cellular localization of SPCC757.11c and the preservation of its epitopes under different fixation conditions.
High background with SPCC757.11c antibodies may be addressed through:
Increasing blocking stringency (5-10% serum, milk, or BSA; "5% v/v ultrapurified BSA in Hank's Buffered Saline Solution" )
Reducing primary antibody concentration
Adding detergents to wash buffers (0.05-0.1% Tween-20)
Extending wash steps (3-5 washes of 5-10 minutes each)
Testing different blocking reagents (BSA vs. serum vs. commercial blockers)
Using fragment-specific secondary antibodies to reduce Fc receptor binding
From the methodology in search result , consider buffer modifications: "for the first step biotinylated UEA-I labeling, the FACS buffer was replaced with a 5% v/v ultrapurified BSA in Hank's Buffered Saline Solution (HBSS)... for all wash steps and for diluting the streptavidin fluorophore to avoid potential reactivity" .
For investigating protein-protein interactions involving SPCC757.11c, researchers should consider:
Co-immunoprecipitation coupled with mass spectrometry
Proximity ligation assays for in situ detection of interactions
FRET or BRET analysis for dynamic interaction studies
Chromatin immunoprecipitation (ChIP) if involved in transcriptional complexes
Yeast two-hybrid screening with SPCC757.11c as bait
Similar approaches have been successfully used with other yeast proteins: "Atf1 and Pcr1 associate with the promoters and coding regions of target genes in response to this carbon source change" , demonstrating how transcription factors can be studied through their DNA interactions.
For quantitative analysis of SPCC757.11c localization:
Use automated image analysis software (ImageJ/FIJI, CellProfiler) for unbiased quantification
Implement colocalization analysis with known organelle markers (Pearson's or Mander's coefficient)
Consider FRAP (Fluorescence Recovery After Photobleaching) for dynamics studies
Use line scan analysis for distribution patterns across cellular compartments
Implement machine learning approaches for pattern recognition in complex images
Similar to the multi-parameter analysis described for other cellular studies: "Extracellular, intracellular, single, and multicolour immunolabeling reactions and FACS analyses were all performed" .
To analyze SPCC757.11c expression changes:
Combine immunoblotting with densitometry for semi-quantitative analysis
Use flow cytometry for single-cell quantification of expression levels
Implement RT-qPCR to correlate protein expression with transcript levels
Consider proteomics approaches for global protein changes
Use time-course experiments with synchronized cultures
The approach should be similar to that described for analyzing expression changes in other yeast proteins: "Atf1 and Pcr1 induce transcription of agl1 when the carbon source is switched from glucose to maltose" . This demonstrates how environmental conditions can influence gene expression, requiring appropriate experimental design to capture these changes.
When selecting SPCC757.11c antibodies, researchers should verify:
Validation method documentation (Western blot, IP, IF, FACS)
Specificity testing (knockout/knockdown validation)
Cross-reactivity testing with related proteins
Lot-to-lot consistency data
Application-specific performance metrics
Quality control approaches similar to those used for other antibodies include extensive validation: "the LIA was subjected to an extensive validation process" including testing against sera from patients and controls .
Based on general antibody principles:
Aliquot antibodies upon receipt to minimize freeze-thaw cycles
Store according to manufacturer recommendations (typically -20°C or -80°C for long-term)
Add preservatives (0.02% sodium azide) for working dilutions stored at 4°C
Monitor for signs of aggregation or precipitation
Test performance of older antibody lots against fresh lots periodically
While no specific storage information for SPCC757.11c antibodies is provided in the search results, these general principles apply to maintain optimal antibody performance.
Cross-reactivity expectations would depend on sequence conservation:
High conservation with other Schizosaccharomyces species (S. japonicus, S. octosporus)
Possible cross-reactivity with orthologous proteins in related yeasts
Limited cross-reactivity with mammalian proteins unless targeting highly conserved domains
Although specific cross-reactivity data for SPCC757.11c antibodies is not available in the search results, researchers should examine sequence homology and validate cross-reactivity experimentally before using these antibodies across species.